LONDON: Moderna Inc is planning to price its coronavirus vaccine at US$50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, the Financial Times reported on Tuesday, citing unnamed sources.
Moderna's proposed price for a two-dose course sold to governments compares with US$39 for two doses under a deal that Pfizer Inc and German partner BioNTech struck with the U.S. government.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
